893), and decision curve analysis demonstrated high net clinical benefit.<h4>Conclusion</h4>Postoperative frailty in advanced ovarian cancer is associated with a multifactorial profile, primarily driven by age, nutritional status, STAI scores, MPO, NE, and Cit-H3 levels. This evidence concerns the gene MPO and ovarian cancer.